Fonte: Circulation. Unidade: FM
Assuntos: DOENÇA CRÔNICA, REGRESSÃO LOGÍSTICA, ANEMIA, ERITROPOIETINA, DIABETES MELLITUS, NEFROPATIAS, ACIDENTE VASCULAR CEREBRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SKALI, Hicham et al. Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience. Circulation, v. 124, n. 25, p. 2903-2908, 2011Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.111.030411. Acesso em: 04 jun. 2024.APA
Skali, H., Parving, H. -H., Parfrey, P. S., Burdmann, E. A., Lewis, E. F., Ivanovich, P., et al. (2011). Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience. Circulation, 124( 25), 2903-2908. doi:10.1161/CIRCULATIONAHA.111.030411NLM
Skali H, Parving H-H, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P, Keithi-Reddy SR, McGill JB, McMurray JJV, Singh AK, Solomon SD, Uno H, Pfeffer MA. Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience [Internet]. Circulation. 2011 ; 124( 25): 2903-2908.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.030411Vancouver
Skali H, Parving H-H, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P, Keithi-Reddy SR, McGill JB, McMurray JJV, Singh AK, Solomon SD, Uno H, Pfeffer MA. Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience [Internet]. Circulation. 2011 ; 124( 25): 2903-2908.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.030411
